Adverum Biotechnologies, Inc. Financial Ratios — ADVM Stock

Profitability (USD)

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-717.34	-31.17	-22.27	-45.6	-25.73	-34.97	-29.57	-33.32	-31.56	-41.31	-52.62	-78.02
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	100	100	100	100	100	100	- -	100	- -	100	100
EBITDA Margin (%)	- -	- -	-4,237.76	-1,916.26	-3,640.34	-3,069.28	-4,425	-26,788.8	- -	-1,886.36	- -	-3,424.94	-13,550.6
Operating Margin (%)	- -	- -	-4,266.08	-1,951.27	-3,750.52	-3,182.64	-4,533.56	-27,418	- -	-1,948.29	- -	-3,581.72	-13,915.9
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	19,762	- -	146.84	- -	- -
Pretax Margin (%)	- -	- -	-4,441.26	-2,046.27	-7,870.93	-3,036.61	-4,582.94	-25,794.4	- -	-1,940.53	- -	-3,422.06	-13,092.7
Profit Margin (%)	- -	- -	-4,441.26	-2,046.27	-7,817.66	-3,036.61	-4,505.4	-25,794.4	- -	-1,940.53	- -	-3,392.11	-13,092.7
Net Income to Common Margin (%)	- -	- -	-5,005.94	-2,046.27	-7,817.66	-3,036.61	-4,505.4	-25,794.4	- -	-1,940.53	- -	-3,392.11	-13,092.7
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	11.28	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Total Debt	- -	- -	- -	- -	- -	- -	- -	32	31	103	107	74	92
ST Debt	- -	- -	- -	- -	- -	- -	- -	4	4	2	13	5	6
LT Debt	- -	- -	- -	- -	- -	- -	- -	28	26	101	94	69	86
Total Debt/EBITDA	-0.27	-0.03	- -	- -	- -	- -	- -	-0.48	-0.27	-0.73	-0.71	-0.6	-0.68
Net Debt/EBITDA	-0.07	0.14	6.58	4.98	4.19	1.24	2.17	0.98	0.55	0.24	0.45	0.61	0.45
Total Debt/EBIT	-0.27	-0.03	- -	- -	- -	- -	- -	-0.47	-0.26	-0.7	-0.68	-0.57	-0.66
Net Debt/EBIT	-0.07	0.14	6.53	4.89	4.07	1.2	2.12	0.96	0.53	0.23	0.44	0.58	0.44
EBITDA to Interest Expense	-226.88	-46.96	-1,346.67	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	-227.25	-48.21	-1,399.06	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	-227	-47.32	-1,355.67	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-930.83	-817.42	-22.68	-31.84	-84.37	-125.83	-150.14	-172.87	-104.14	-147.38	-260.27	-600.91	-593.27
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	16.13	6.04	31.98	51.54	102	121.67
Long-Term Debt/Capital (%)	-76.14	-11.58	- -	- -	- -	- -	- -	-8	-5.56	-18.55	-13.45	-7.95	-8.82
Long-Term Debt/Total Assets (%)	125.65	8.39	- -	- -	- -	- -	- -	12.67	5.44	22.99	30.34	44.02	47.84
Total Debt/Equity (%)	-48.65	-41.74	- -	- -	- -	- -	- -	18.43	7.07	32.57	58.84	110.14	129.68
Total Debt/Capital (%)	-76.14	-11.58	- -	- -	- -	- -	- -	-9.14	-6.51	-18.9	-15.35	-8.59	-9.4
Total Debt/Total Assets (%)	125.65	8.39	- -	- -	- -	- -	- -	14.48	6.36	23.42	34.63	47.53	50.99
Net Debt to Equity	-12.84	216.97	-106.64	-87.63	-103.05	-38.32	-77.03	-37.66	-14.37	-10.81	-37.7	-111.57	-85.77
Net Debt/Capital (%)	-12.88	35.04	81.28	72.45	52.89	21.73	32.59	15.74	11.68	5.9	8.95	8	5.86
EBITDA	-2	-3	-24	-44	-53	-57	-71	-67	-114	-141	-151	-123	-136
EBITDA-CapEx	-2	-4	-25	-47	-55	-58	-72	-86	-126	-157	-162	-124	-136
Operating Income (Loss)	-2	-3	-24	-45	-55	-59	-73	-69	-118	-146	-157	-129	-139

Liquidity (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Cash Ratio	0.43	0.49	29.14	39.41	22.45	17.85	19.13	8.55	20.59	14.31	5.76	4.83	5.49
Current Ratio	0.46	0.71	29.3	39.7	22.76	18.15	19.48	9.06	20.82	14.88	5.91	5.14	5.73
Quick Ratio	0.43	0.49	29.14	39.48	22.54	17.85	19.13	8.55	20.59	14.58	5.76	4.83	5.49
CFO/Avg Current Liab	- -	-2.17	-1.7	-5.87	-4.66	-4.42	-5.05	-3.26	-3.94	-5.11	-4.04	-3.48	-4.31
Common Equity/Total Assets	-930.83	-817.42	-22.68	-31.84	-84.37	-125.83	-150.14	-172.87	-104.14	-147.38	-260.27	-600.91	-593.27
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	16.13	6.04	31.98	51.54	102	121.67
Long-Term Debt/Capital (%)	-76.14	-11.58	- -	- -	- -	- -	- -	-8	-5.56	-18.55	-13.45	-7.95	-8.82
Long-Term Debt/Total Assets (%)	125.65	8.39	- -	- -	- -	- -	- -	12.67	5.44	22.99	30.34	44.02	47.84
Total Debt/Equity (%)	-48.65	-41.74	- -	- -	- -	- -	- -	18.43	7.07	32.57	58.84	110.14	129.68
Total Debt/Capital (%)	-76.14	-11.58	- -	- -	- -	- -	- -	-9.14	-6.51	-18.9	-15.35	-8.59	-9.4
Total Debt/Total Assets (%)	125.65	8.39	- -	- -	- -	- -	- -	14.48	6.36	23.42	34.63	47.53	50.99
CFO/Total Liabilities	-91.61	-166.92	-45.46	-301.34	-202.11	-254.08	-437.74	-102.93	-164.44	-87.28	-85.21	-102.66	-84.73
CFO/CapEx	-422.33	-23.9	-5.99	-11.81	-15.91	-44.71	-66.7	-2.55	-6.69	-7.13	-9.15	-112.5	-238.3
Altman's Z-Score	-29.98	-22.33	59.68	12.75	2.46	3.46	7.3	6.68	10.25	-1.5	-4.44	-9.97	-9.62

Working Capital (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Accounts Receivable Turnover	- -	- -	143	10.33	2.18	4.17	- -	- -	- -	2.63	- -	- -	- -
Days Sales Outstanding	- -	- -	2.55	35.34	167.45	87.45	- -	- -	- -	138.92	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Market Capitalization	- -	- -	1,229	246	105	153	193	738	923	173	58	76	92
- Cash & Cash Equivalents	- -	1	159	221	222	71	155	66	62	34	68	75	61
+ Preferred Equity and Hybrid Capital	2	8	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	32	31	103	107	74	92
Enterprise Value	3	8	1,069	-13	-117	-38	-12	605	524	-30	-21	53	58
Total Capital	-1	-1	-37	-84	-198	-254	-321	-353	-472	-545	-696	-862	-975
Total Debt/Capital (%)	-76.14	-11.58	- -	- -	- -	- -	- -	-9.14	-6.51	-18.9	-15.35	-8.59	-9.4
Total Debt / EV	0.19	0.01	- -	- -	- -	- -	- -	0.05	0.06	-3.47	-5.03	1.39	1.57
EV/Sales	- -	- -	1,869.43	- -	- -	- -	- -	2,418.67	- -	- -	- -	14.84	58.4
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	1,229	246	105	153	193	738	923	173	58	76	92
Diluted Enterprise Value	3	8	1,069	25	-117	82	38	705	891	241	96	75	123
EV per Share	1.25	3.62	469.94	- -	- -	- -	- -	94.33	61.54	- -	- -	5.3	2.95
TTM Sales	- -	- -	1	2	1	2	2	- -	- -	8	- -	4	1
TTM EBITDA	-2	-3	-24	-44	-53	-57	-71	-67	-114	-141	-151	-123	-136
TTM Operating Income	-2	-3	-24	-45	-55	-59	-73	-69	-118	-146	-157	-129	-139
TTM Cash Flow to Firm	-1	-2	-6	-35	-38	-45	-54	-49	-79	-108	-108	-91	-92
TTM Free Cash Flow to Firm	-1	-2	-5	-32	-36	-44	-53	-30	-67	-93	-96	-90	-92

Multiples (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Price/Free Cash Flow	- -	- -	-261.15	-7.61	-2.92	-3.44	-3.64	-24.68	-13.68	-1.86	-0.6	-0.84	-1
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	3	8	1,069	-13	-117	-38	-12	605	524	-30	-21	53	58
Low Price	- -	- -	220	74	27.4	24	26.2	29	73.6	16.9	5.31	5.75	4.42
EV/Sales	- -	- -	1,869.43	- -	- -	- -	- -	2,418.67	- -	- -	- -	14.84	58.4
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-27.82	-13.16	-1.36	-2.26	-4.63	-8.1	-10.28	-3.64	-0.74	-0.92	-1.44
Price/Earnings High	- -	- -	-45.59	-34.05	-2.98	-3.27	-7.26	-16.29	-19.55	-9.96	-1.31	-1.93	-4.49
Price/Earnings Low	- -	- -	-17.48	-4.03	-0.87	-1.87	-2.21	-2.88	-5.33	-1.14	-0.34	-0.47	-0.67
Price/Book Value	- -	- -	-33.47	-2.92	-0.53	-0.6	-0.6	-1.92	-1.84	-0.27	-0.07	-0.08	-0.09
Price/Book Value Average	- -	- -	-21.7	-7.42	-0.78	-0.5	-1.05	-1.36	-2.4	-0.82	-0.14	-0.12	-0.18
Price/Book Value High	- -	- -	-35.56	-19.2	-1.72	-0.72	-1.64	-2.73	-4.57	-2.24	-0.25	-0.25	-0.55
Price/Book Value Low	- -	- -	-13.64	-2.27	-0.5	-0.41	-0.5	-0.48	-1.25	-0.26	-0.07	-0.06	-0.08
Price/Tangible Book Value	- -	- -	8.22	0.97	0.5	0.85	0.96	4.22	2.12	0.55	0.32	1.13	1.31
Price/Tangible Book Value Average	- -	- -	5.33	2.47	0.74	0.71	1.67	2.99	2.78	1.68	0.63	1.68	2.67
Price/Tangible Book Value High	- -	- -	8.73	6.4	1.61	1.02	2.62	6	5.29	4.59	1.12	3.51	8.31
Price/Tangible Book Value Low	- -	- -	3.35	0.76	0.47	0.59	0.8	1.06	1.44	0.52	0.29	0.86	1.24
Price/Sales	- -	- -	2,148.11	106.16	72.24	82.65	119.93	2,953.82	- -	23.01	- -	21.09	92.38
Price/Sales Average	- -	- -	1,392.84	269.22	106.61	68.75	208.52	2,089.15	- -	70.71	- -	31.33	189.1
Price/Sales High	- -	- -	2,282.17	696.7	233.29	99.18	327.05	4,200.73	- -	193.33	- -	65.53	587.53
Price/Sales Low	- -	- -	875.16	82.52	68.26	56.67	99.75	743.58	- -	22.09	- -	16.1	87.44
Price/Cash Flow	- -	- -	-217.55	-6.97	-2.74	-3.36	-3.58	-15.02	-11.64	-1.6	-0.53	-0.84	-1
Price/Cash Flow Average	- -	- -	-141.06	-17.67	-4.04	-2.8	-6.23	-10.62	-15.23	-4.92	-1.05	-1.24	-2.05
Price/Cash Flow High	- -	- -	-231.13	-45.72	-8.85	-4.04	-9.77	-21.36	-28.97	-13.45	-1.87	-2.6	-6.35
Price/Cash Flow Low	- -	- -	-88.63	-5.41	-2.59	-2.31	-2.98	-3.78	-7.9	-1.54	-0.49	-0.64	-0.95
Price/Free Cash Flow Average	- -	- -	-169.33	-19.3	-4.31	-2.86	-6.32	-17.45	-17.91	-5.72	-1.18	-1.25	-2.05
Price/Free Cash Flow High	- -	- -	-277.45	-49.95	-9.44	-4.13	-9.92	-35.1	-34.06	-15.64	-2.1	-2.62	-6.38
Price/Free Cash Flow Low	- -	- -	-106.4	-5.92	-2.76	-2.36	-3.03	-6.21	-9.29	-1.79	-0.55	-0.64	-0.95
EV/Sales Average	- -	- -	1,114.16	173.77	- -	30.61	112.4	1,954.55	- -	79.89	- -	31.06	220.16
EV/Sales High	- -	- -	2,003.49	601.25	80.6	61.04	230.93	4,066.14	- -	202.51	- -	65.27	618.58
EV/Sales Low	- -	- -	596.48	- -	- -	18.53	3.63	608.99	- -	31.26	- -	15.84	118.49
EV/EBITDA Average	-1.43	-2.19	-26.29	-9.07	1.27	-1	-2.54	-7.3	-10.34	-4.24	-1.01	-0.91	-1.62
EV/EBITDA High	-1.43	-2.19	-47.28	-31.38	-2.21	-1.99	-5.22	-15.18	-19.91	-10.74	-1.6	-1.91	-4.56
EV/EBITDA Low	-1.43	-2.19	-14.08	0.67	2.32	-0.6	-0.08	-2.27	-5.23	-1.66	-0.6	-0.46	-0.87
EV/EBIT Average	-1.43	-2.18	-26.12	-8.91	1.23	-0.96	-2.48	-7.13	-9.97	-4.1	-0.97	-0.87	-1.58
EV/EBIT High	-1.43	-2.18	-46.96	-30.81	-2.15	-1.92	-5.09	-14.83	-19.21	-10.39	-1.53	-1.82	-4.45
EV/EBIT Low	-1.43	-2.18	-13.98	0.66	2.25	-0.58	-0.08	-2.22	-5.04	-1.6	-0.58	-0.44	-0.85
Last Price	- -	- -	540	95.2	29	35	31.5	115.2	108.4	17.6	5.8	7.53	4.67
High Price	- -	- -	573.7	624.8	93.65	42	85.9	163.83	269.8	147.9	20.4	23.4	29.7
Enterprise Value Average	3	8	637	403	-67	57	181	489	1,176	599	152	112	220
Enterprise Value High	3	8	1,146	1,394	117	113	372	1,017	2,266	1,519	241	235	619
Enterprise Value Low	3	8	341	-30	-123	34	6	152	595	234	91	57	118

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Shares Outstanding	2	2	2	3	4	5	6	7	10	10	10	10	21
Diluted Weighted Avg Shares	2	2	2	3	4	4	6	6	9	10	10	10	20
Basic Weighted Avg Shares	2	2	2	3	4	4	6	6	9	10	10	10	20
Revenue per Share	- -	- -	0.25	0.9	0.4	0.42	0.26	0.04	- -	0.77	- -	0.36	0.05
EBITDA per Share	-0.87	-1.65	-10.65	-17.18	-14.61	-13	-11.62	-10.45	-13.36	-14.43	-15.17	-12.23	-6.85
Operating Income per Share	-0.87	-1.66	-10.72	-17.5	-15.06	-13.48	-11.91	-10.69	-13.85	-14.9	-15.83	-12.79	-7.03
Basic EPS, GAAP	-0.87	-2.54	-12.58	-18.35	-31.38	-12.86	-11.83	-10.06	-13.8	-14.85	-15.57	-12.11	-6.62
Basic EPS from Cont Ops	-0.87	-2.54	-11.16	-18.35	-31.38	-12.86	-11.83	-10.06	-13.8	-14.85	-15.57	-12.11	-6.62
Diluted EPS, GAAP	-0.87	-2.54	-12.58	-18.35	-31.38	-12.86	-11.83	-10.06	-13.8	-14.85	-15.57	-12.11	-6.62
Diluted EPS from Cont Ops	-0.87	-2.54	-11.16	-18.35	-31.38	-12.86	-11.83	-10.06	-13.8	-14.85	-15.57	-12.11	-6.62
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.61	-1.05	-2.48	-13.67	-10.58	-10.4	-8.79	-7.67	-9.31	-11	-10.89	-9.02	-4.67
Free Cash Flow per Basic Share	-0.61	-1.09	-2.9	-14.82	-11.25	-10.64	-8.92	-10.67	-10.7	-12.54	-12.08	-9.1	-4.69
Cash & Equivalents per Share	0.17	0.27	70.06	100.19	61.3	43.63	33.41	25.9	50.47	31.13	18.7	9.57	6.35
Book Value per Share	-1.73	-4.27	-16.13	-32.55	-54.6	-58.19	-52.23	-60.06	-59.02	-66.1	-80.87	-92.84	-53.94
Tangible Book Value per Share	-1.67	-3.95	65.7	97.68	58.1	41	32.78	27.29	51.01	32.25	18.29	6.67	3.57

Adverum Biotechnologies, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)